Cytokinetics is a biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for people with debilitating diseases in which muscle performance is compromised and/or declining. Founded in South San Francisco, California, by pioneers in the field of muscle biology, we have been leveraging our scientific expertise to develop new medicines for patients for over 25 years.
A leader in muscle biology research
With more than 115 publications, over 100 clinical trials, and hundreds of issued patents, Cytokinetics continues to pursue opportunities on the forefront of scientific research by expanding into research activities focused to the energetics, growth and metabolism of muscle. We are a team of innovators, creators, solution seekers and dreamers.
